Filing Details
- Accession Number:
- 0001209191-21-063222
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-05 17:17:34
- Reporting Period:
- 2021-10-01
- Accepted Time:
- 2021-11-05 17:17:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1075050 | J A Kazimi | 2525 West End Ave. Suite 950 Nashville TN 37203 | Chairman And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-10-01 | 15 | $2.69 | 5,769,474 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-04 | 15 | $2.87 | 5,769,489 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-05 | 15 | $2.82 | 5,769,504 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-06 | 15 | $2.76 | 5,769,519 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-07 | 15 | $2.76 | 5,769,534 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-08 | 15 | $2.84 | 5,769,549 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-11 | 15 | $2.73 | 5,769,564 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-12 | 15 | $2.71 | 5,769,579 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-13 | 15 | $2.71 | 5,769,594 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-14 | 15 | $2.81 | 5,769,609 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-15 | 15 | $2.76 | 5,769,624 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-18 | 15 | $2.75 | 5,769,639 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-19 | 15 | $2.76 | 5,769,654 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-20 | 15 | $2.63 | 5,769,669 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-21 | 15 | $2.65 | 5,769,684 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-22 | 15 | $2.66 | 5,769,699 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-25 | 15 | $2.64 | 5,769,714 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-26 | 15 | $2.64 | 5,769,729 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-27 | 15 | $2.61 | 5,769,744 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-28 | 15 | $2.61 | 5,769,759 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-29 | 15 | $2.72 | 5,769,774 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
Billionaire Hedge Funds
